4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-062982
Chief Executive Officer sold 3,075 shares at $0.75 ($2,304)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-17 | Sale : show line 1 in the form | −3,075 | $0.75 | $2,304 | 789,620 | D |
| Open-market sales · 3,075 sh · avg $0.75 · $2,304 | ||||||
Loading xslF345X05/ownership.xml…